Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. [electronic resource]
Producer: 20080402Description: 156-65 p. digitalISSN:- 0024-3205
- Adenoviridae -- genetics
- Animals
- Bradykinin -- analogs & derivatives
- Bradykinin B2 Receptor Antagonists
- Enzyme Inhibitors -- pharmacology
- Gene Expression
- Gene Transfer Techniques
- Heart Function Tests
- Heart Ventricles -- drug effects
- Hemodynamics -- genetics
- Humans
- Kallikreins -- antagonists & inhibitors
- Male
- Myocardial Infarction -- genetics
- Myocardial Reperfusion Injury -- genetics
- Myocarditis -- genetics
- Myocardium -- metabolism
- NG-Nitroarginine Methyl Ester -- pharmacology
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type II -- antagonists & inhibitors
- Nitric Oxide Synthase Type III
- Phosphorylation -- drug effects
- Rats
- Rats, Wistar
- Receptor, Bradykinin B2 -- metabolism
- Ventricular Remodeling -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.